A    B    C    D    E    F    G    H    I    J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z    

Upadacitinib-D2,15N



Upadacitinib-D2,15N Cas No.1310726-60-3(unlabelled)

Make a quick enquiry

1

  • Synonyms:(3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl-1,1-d2)pyrrolidine-1-carboxamide-N-15N
  • Chemical Name:Upadacitinib-D2,15N
  • Country of Origin:India
  • Application Notes:Upadacitinib-D2,15N is an isotopic labelled compound of Upadacitinib (U800075), a potent and selective Janus kinase (JAK) 1 inhibitor being developed for the treatment of several autoimmune disorders, Janus kinase inhibitors for rheumatoid arthritis.
  • Product Category:Upadacitinib Stable Isotopes

    Upadacitinib-D2,15N is identified by CAS No. 1310726-60-3(unlabelled) and is chemically known as (3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl-1,1-d2)pyrrolidine-1-carboxamide-N-15N.

    Upadacitinib-D2,15N is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Upadacitinib.


    Page Keywords: Buy Upadacitinib-D2,15N | Purchase Upadacitinib-D2,15N | Upadacitinib-D2,15N suppliers | Upadacitinib-D2,15N manufacturers | Upadacitinib-D2,15N price | Upadacitinib-D2,15N Importer | Upadacitinib-D2,15N Exporter

    Disclaimer:
    The product information for any accuracy or completeness is as per the existing knowledge furnished during the creation of the webpage.
    The purchaser, user or importer of record is responsible for determining the accuracy of items at the time of ordering as it may change without notice as per current product specification.
    This product is solely intended for research purposes and is not approved for human consumption.







Request For Quote


Related products

Show details of Upadacitinib D2